Lawsuit probes fairness of Select Medical's $16.50/share privatization deal amid higher analyst price target.

Kaskela Law is investigating whether Select Medical's $16.50 per share buyout offer is fair to public shareholders, following the company's agreement to be acquired by an investment group. The investigation questions if shareholders are receiving adequate compensation, especially since some analysts had valued the shares at $19.00. If completed, Select Medical will be privatized and its shares delisted. Shareholders are encouraged to contact Kaskela Law to explore their legal options regarding the deal.